The sudden outbreak of the COVID-19 epidemic has given more significant attention to solving the problem of acute respiratory viral infections. In this regard, the Ministry of Health of the Russian Federation and the Federal Service for Supervision of Consumer Rights Protection and Human Well-Being have issued Temporary Guidelines for the prevention, diagnosis and treatment of new coronavirus infection, which are of interest to practitioners of the healthcare system. The purpose of this study is to conduct a comparative analysis of the stages of administration of drugs for the treatment of COVID-19 in adults. We have analyzed the medicines recommended by the Temporary Guidelines for the treatment of COVID-19 in adults for the period from 29.01.2020 to 18.08.2022. The structural analysis of the membership of drug groups for the treatment of COVID-19 according to the anatomical-therapeutic-chemical classification was carried out. Medicines were divided into groups and subgroups depending on their effect on a certain anatomical organ or system.

antiviral drugs, coronavirus infection, Temporary guidelines for the prevention, diagnosis and treatment of new coronavirus infection.